| Product Code: ETC7741523 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Shubham Padhi | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Japan Live Attenuated Vaccines Market Overview |
3.1 Japan Country Macro Economic Indicators |
3.2 Japan Live Attenuated Vaccines Market Revenues & Volume, 2021 & 2031F |
3.3 Japan Live Attenuated Vaccines Market - Industry Life Cycle |
3.4 Japan Live Attenuated Vaccines Market - Porter's Five Forces |
3.5 Japan Live Attenuated Vaccines Market Revenues & Volume Share, By Product Type, 2021 & 2031F |
3.6 Japan Live Attenuated Vaccines Market Revenues & Volume Share, By Development, 2021 & 2031F |
3.7 Japan Live Attenuated Vaccines Market Revenues & Volume Share, By Indication, 2021 & 2031F |
3.8 Japan Live Attenuated Vaccines Market Revenues & Volume Share, By Mode of Administration, 2021 & 2031F |
3.9 Japan Live Attenuated Vaccines Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
3.10 Japan Live Attenuated Vaccines Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 Japan Live Attenuated Vaccines Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Growth in the prevalence of infectious diseases in Japan |
4.2.2 Increasing awareness and acceptance of vaccination among the population |
4.2.3 Government initiatives to promote vaccination programs |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for approval of vaccines |
4.3.2 High cost associated with research development of live attenuated vaccines |
4.3.3 Concerns regarding vaccine safety and side effects |
5 Japan Live Attenuated Vaccines Market Trends |
6 Japan Live Attenuated Vaccines Market, By Types |
6.1 Japan Live Attenuated Vaccines Market, By Product Type |
6.1.1 Overview and Analysis |
6.1.2 Japan Live Attenuated Vaccines Market Revenues & Volume, By Product Type, 2021- 2031F |
6.1.3 Japan Live Attenuated Vaccines Market Revenues & Volume, By Bacterial, 2021- 2031F |
6.1.4 Japan Live Attenuated Vaccines Market Revenues & Volume, By Viral, 2021- 2031F |
6.2 Japan Live Attenuated Vaccines Market, By Development |
6.2.1 Overview and Analysis |
6.2.2 Japan Live Attenuated Vaccines Market Revenues & Volume, By Tissue Culture, 2021- 2031F |
6.2.3 Japan Live Attenuated Vaccines Market Revenues & Volume, By Embryonated Eggs, 2021- 2031F |
6.2.4 Japan Live Attenuated Vaccines Market Revenues & Volume, By Live Animals, 2021- 2031F |
6.3 Japan Live Attenuated Vaccines Market, By Indication |
6.3.1 Overview and Analysis |
6.3.2 Japan Live Attenuated Vaccines Market Revenues & Volume, By Tuberculosis, 2021- 2031F |
6.3.3 Japan Live Attenuated Vaccines Market Revenues & Volume, By Measles, 2021- 2031F |
6.3.4 Japan Live Attenuated Vaccines Market Revenues & Volume, By Rotavirus, 2021- 2031F |
6.3.5 Japan Live Attenuated Vaccines Market Revenues & Volume, By Yellow Fever, 2021- 2031F |
6.3.6 Japan Live Attenuated Vaccines Market Revenues & Volume, By Oral Polio, 2021- 2031F |
6.3.7 Japan Live Attenuated Vaccines Market Revenues & Volume, By Others, 2021- 2031F |
6.4 Japan Live Attenuated Vaccines Market, By Mode of Administration |
6.4.1 Overview and Analysis |
6.4.2 Japan Live Attenuated Vaccines Market Revenues & Volume, By Injectable, 2021- 2031F |
6.4.3 Japan Live Attenuated Vaccines Market Revenues & Volume, By Oral, 2021- 2031F |
6.4.4 Japan Live Attenuated Vaccines Market Revenues & Volume, By Others, 2021- 2031F |
6.5 Japan Live Attenuated Vaccines Market, By Distribution Channel |
6.5.1 Overview and Analysis |
6.5.2 Japan Live Attenuated Vaccines Market Revenues & Volume, By Hospital Pharmacies, 2021- 2031F |
6.5.3 Japan Live Attenuated Vaccines Market Revenues & Volume, By Retail Pharmacies, 2021- 2031F |
6.5.4 Japan Live Attenuated Vaccines Market Revenues & Volume, By Online Pharmacies, 2021- 2031F |
6.6 Japan Live Attenuated Vaccines Market, By End User |
6.6.1 Overview and Analysis |
6.6.2 Japan Live Attenuated Vaccines Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.6.3 Japan Live Attenuated Vaccines Market Revenues & Volume, By Homecare, 2021- 2031F |
6.6.4 Japan Live Attenuated Vaccines Market Revenues & Volume, By Specialty Clinics, 2021- 2031F |
6.6.5 Japan Live Attenuated Vaccines Market Revenues & Volume, By Others, 2021- 2031F |
7 Japan Live Attenuated Vaccines Market Import-Export Trade Statistics |
7.1 Japan Live Attenuated Vaccines Market Export to Major Countries |
7.2 Japan Live Attenuated Vaccines Market Imports from Major Countries |
8 Japan Live Attenuated Vaccines Market Key Performance Indicators |
8.1 Vaccination coverage rate among target population |
8.2 Number of new vaccine development initiatives in Japan |
8.3 Adverse events following immunization (AEFI) reporting rate |
8.4 Immunization rate among children and adults |
8.5 Public perception and trust in vaccination effectiveness |
9 Japan Live Attenuated Vaccines Market - Opportunity Assessment |
9.1 Japan Live Attenuated Vaccines Market Opportunity Assessment, By Product Type, 2021 & 2031F |
9.2 Japan Live Attenuated Vaccines Market Opportunity Assessment, By Development, 2021 & 2031F |
9.3 Japan Live Attenuated Vaccines Market Opportunity Assessment, By Indication, 2021 & 2031F |
9.4 Japan Live Attenuated Vaccines Market Opportunity Assessment, By Mode of Administration, 2021 & 2031F |
9.5 Japan Live Attenuated Vaccines Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
9.6 Japan Live Attenuated Vaccines Market Opportunity Assessment, By End User, 2021 & 2031F |
10 Japan Live Attenuated Vaccines Market - Competitive Landscape |
10.1 Japan Live Attenuated Vaccines Market Revenue Share, By Companies, 2024 |
10.2 Japan Live Attenuated Vaccines Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here